NIWA Rinpei | Antibody Research Laboratories, Research Division, Kyowa Hakko Kirin Co., Ltd

スポンサーリンク

概要

• 同名の論文著者
• Antibody Research Laboratories, Research Division, Kyowa Hakko Kirin Co., Ltdの論文著者

関連著者

• Shitara Kenya

  協和醗酵工業東京研究所

• Shitara Kenya

  Department Of Antibody Research Pharmaceutical Research Center Kyowa Hakko Kogyo Co. Ltd.

• Shitara Kenya

  Tokyo Research Laboratories Kyowa Hakko Kogyo Co. Ltd.

• Niwa Rinpei

  Department Of Antibody Research Pharmaceutical Research Center Kyowa Hakko Kogyo Co. Ltd.

• Satoh Mitsuo

  Antibody Research Laboratories Kyowa Hakko Kirin Co. Ltd

• NIWA Rinpei

  Antibody Research Laboratories, Research Division, Kyowa Hakko Kirin Co., Ltd

• Niwa Rinpei

  Antibody Research Laboratories Kyowa Hakko Kirin Co. Ltd

• Shitara Kenya

  Department Of Strategic Product Planning Kyowa Hakko Kirin Co. Ltd

• Hanai Nobuo

  Biowa Inc.

• Natsume Akito

  Department Of Antibody Research Pharmaceutical Research Center Kyowa Hakko Kogyo Co. Ltd.

• NATSUME Akito

  Antibody Research Laboratories, Research Division, Kyowa Hakko Kirin Co., Ltd

• SHIMIZU YOKOYAMA

  Antibody Research Laboratories, Research Division, Kyowa Hakko Kirin Co., Ltd

• SHITARA Kenya

  Strategic Product Planning Department, Kyowa Hakko Kirin Co., Ltd

• KUBOTA Tsuguo

  Antibody Research Laboratories, Kyowa Hakko Kirin Co., Ltd

• AKINAGA Shiro

  Department of Clinical Development, Kyowa Hakko Kirin Co., Ltd

• HANAI Nobuo

  Department of Development Division, Kyowa Hakko Kirin Co., Ltd

• Shimizu Yokoyama

  Antibody Research Laboratories Research Division Kyowa Hakko Kirin Co. Ltd

• Natsume Akito

  Antibody Research Laboratories Research Division Kyowa Hakko Kirin Co. Ltd

• Akinaga Shiro

  Department Of Clinical Development Kyowa Hakko Kirin Co. Ltd

• Hanai Nobuo

  Department Of Development Division Kyowa Hakko Kirin Co. Ltd

• Kubota Tsuguo

  Antibody Research Laboratories Kyowa Hakko Kirin Co. Ltd

• Akinaga Shiro

  Department of Chemistry, School of Science and Engineering, Waseda University

もっと見る 閉じる

著作論文

• Engineered anti-CD20 antibodies with enhanced complement-activating capacity mediate potent anti-lymphoma activity
• Engineered therapeutic antibodies with improved effector functions

スポンサーリンク